---
layout: post
title: "Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2026"
date: 2026-02-04 21:48:57 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-14409
original_published: 2025-07-30 00:00:00 +0000
significance: 8.00
---

# Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2026

**Published:** February 04, 2026 21:48 UTC
**Source:** Federal Register
**Original Published:** July 30, 2025 00:00 UTC
**Document Number:** 2025-14409

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the fee rates and payment procedures for fiscal year (FY) 2026 generic new animal drug program user fees. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Animal Generic Drug User Fee Amendments of 2023 (AGDUFA IV), authorizes FDA to collect user fees for certain abbreviated applications for generic new animal drugs, for certain generic new animal drug products, for certain sponsors of such abbreviated applications for generic new animal drugs and/or investigational submissions for generic new animal drugs (JINADs), and for certain submissions related to JINAD files. This notice establishes the fee rates for FY 2026.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/07/30/2025-14409/animal-generic-drug-user-fee-program-rates-and-payment-procedures-for-fiscal-year-2026)
- API: https://www.federalregister.gov/api/v1/documents/2025-14409

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
